Clinical Trials in Atlanta

Showing 9261-9280 of 19,805 trials

A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS

NCT02267863

This study is being done to evaluate the safety and effectiveness of APTO-253 for the treatment of patients with the condition of acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) for which either the standard treatment has failed, is no longer effective, or can no longer be administered safely or poses a risk for your general well being.

Acute Myelogenous Leukemia in RelapseAcute Myelogenous Leukemia, Relapsed, AdultAcute Myelogenous Leukemia, Adult+2 more

Aptose Biosciences Inc.21 participantsStarted Oct 2014

Tucson, Arizona, United States • La Jolla, California, United States • Orange, California, United States +10 more locations

COMPLETEDNA< 1 mile

Diagnosing Intensive Care Unit (ICU) Acquired Weakness

NCT04166630

The goal of this study is to develop a non-invasive test to diagnose intensive care unit (ICU) acquired weakness that can be administered to both responsive and non-responsive patients. Study participation will involve the measurement of muscle fatigue during a single 30 minute session. Skeletal muscle will be stimulated with an FDA approved clinical electrical stimulator and accelerations will be passively recorded with an accelerometer.

ICU Acquired Weakness

Emory University22 participantsStarted Feb 2021

Atlanta, Georgia, United States

A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS

Diagnosing Intensive Care Unit (ICU) Acquired Weakness

Find Trials by Condition in Atlanta

Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients

A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis

Soccer-based Adaptation of the Diabetes Prevention Program

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Canagliflozin-Mealtime Insulin Rescue

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)

Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease

Genomic Translation for Amyotrophic Lateral Sclerosis Care

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients